Business Context and Reporting Period
Company: Constellium SE
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2026
Event: Authorization of a new share repurchase program by the Board of Directors.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the authorization of a capital allocation program.
Material Changes
- New Share Repurchase Program: The Board authorized a program to repurchase up to $300 million of outstanding ordinary shares.
- Program Timeline: The program is effective following the 2026 Annual General Meeting of Shareholders on May 21, 2026, and expires on December 31, 2028.
- Replacement: This new program replaces the share repurchase program authorized in February 2024.
Guidance, Outlook, and Risks
The filing contains no specific financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure of the repurchase program mechanics. The program is subject to market conditions and other factors, as is typical for such authorizations, though specific constraints are not detailed in this text.
Investor Verification Checklist
- Verify the exact timing of the 2026 Annual General Meeting (May 21, 2026) to confirm the program's effective date.
- Review the attached press release (Exhibit 99.1) for details on the methodology of repurchases (e.g., open market vs. private transactions).
- Confirm the status of the previous February 2024 repurchase program to ensure no overlap or unutilized balance remains.
- Monitor future filings for actual repurchase activity and remaining authorization amounts.